Evalution and Development of Antidiabetic Effervescent Tablet of Caffeine

Researchers have emphasized the beneficial effects of coffee drinking on blood sugar management in humans. Conversely, the common medication used to treat type 2 diabetes is metformin. The purpose of this study was to investigate potential uses of coffee as an adjuvant to metformin or as a stand-alone treatment for type 2 diabetes Serum HbA levels were considerably lower in groups treated with black coffee (Group 3), metformin (Group 4), and black coffee with metformin (Group 5) than in the 1C diabetic control group (Group 2) (P<0.05).Acceptable salt of metformin, an acid compound or acid salt, an alkaline effervescing compound, one or more compressible binders, and one or more excipients are the components of the effervescent composition of metformin that is the subject of the invention. The weight ratio of the acid compound or acid salt (b) to the alkaline effervescing compound (c) must be greater than 2:1. Tablets and granules made from them are likewise covered by the invention. The invention also pertains to methods for producing effervescent tablets and granules, as well as a method for preparing said composition. The invention specifically targets formulations of metformin hydrochloride as well as the tablets and granules derived from them.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-11
DOI
https://doi.org/10.5281/zenodo.15005457
Primary Topic
Research Data Management Practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evalution and Development of Antidiabetic Effervescent Tablet of Caffeine

Zenodo (CERN European Organization for Nuclear Research)
Research Data Management Practices
article

Evalution and Development of Antidiabetic Effervescent Tablet of Caffeine

article en

Abstract

Researchers have emphasized the beneficial effects of coffee drinking on blood sugar management in humans. Conversely, the common medication used to treat type 2 diabetes is metformin. The purpose of this study was to investigate potential uses of coffee as an adjuvant to metformin or as a stand-alone treatment for type 2 diabetes Serum HbA levels were considerably lower in groups treated with black coffee (Group 3), metformin (Group 4), and black coffee with metformin (Group 5) than in the 1C diabetic control group (Group 2) (P<0.05).Acceptable salt of metformin, an acid compound or acid salt, an alkaline effervescing compound, one or more compressible binders, and one or more excipients are the components of the effervescent composition of metformin that is the subject of the invention. The weight ratio of the acid compound or acid salt (b) to the alkaline effervescing compound (c) must be greater than 2:1. Tablets and granules made from them are likewise covered by the invention. The invention also pertains to methods for producing effervescent tablets and granules, as well as a method for preparing said composition. The invention specifically targets formulations of metformin hydrochloride as well as the tablets and granules derived from them.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 39%
Research Data Management Practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.